Stayble strengthens its team by recruiting VP CMC and Regulatory Affairs
Stayble Therapeutics announced today that the company is strengthening its team by recruiting Dr. Sara Richardson in the newly created role VP CMC and Regulatory Affairs. Dr. Richardson will primarily work with the company's continued clinical development, particularly with manufacturing issues (CMC), regulatory issues and government interactions."Dr. Richardson will play a key role in the company, especially in the ongoing clinical development of our drug candidate STA363. I am very happy to welcome Dr. Richardson to the team with her expertise and experience being very valuable for our